Drug Type Autologous CAR-T |
Synonyms KQ-L6自体嵌合抗原受体T细胞, KQ L6, KQ-L6 + [1] |
Target |
Action inhibitors |
Mechanism TM4SF1 inhibitors(transmembrane 4 L six family member 1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization- |
Drug Highest PhaseIND Application |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Colorectal Cancer | Clinical | - | 30 Jan 2023 | |
Stomach Cancer | Clinical | - | 30 Jan 2023 | |
Solid tumor | IND Application | China | 06 Sep 2022 |